High endothelial venules (HEVs): specialized blood vessels for lymphocyte entry in tumors during cancer immunotherapy #TIJC 11

WEBINAR Transdisciplinary Immunology Journal Club #TIJC10
With Lucas Blanchard
High endothelial venules (HEVs): specialized blood vessels for lymphocyte entry in tumors during cancer immunotherapy
Thursday, November 20, 2025 - From 4:00 PM to 5:00 PM

REGISTRATION here >> to get the ZOOM link!

Revoir en Replay TIJC#7
Anti-PD-1 amplifies co-stimulation in melanoma-infiltrating Th1-like Foxp3+ Regulatory T cells to alleviate local immunosuppression par Dr Mikhaël ATTIAS

 

Revoir en Replay TIJC#6bis
HLA class I peptide polymorphisms contribute to class II DQβ0603:DQα0103 antibody specificity par le Dr Cédric Usureau

Revoir en Replay TIJC#6
Evolution of myeloid-mediated immunotherapy resistance in prostate cancer : Lyu A & al. Nature.2025  par le Dr Simon COIBA, disponible ICI

Revoir en Replay TIJC#5
Neoantigen vaccines: a new era of precision medicine in oncology par le Dr Adrien MOUREN, disponible ICI

Revoir en Replay TIJC#4
Hallmarks of CD8+ T cell dysfunction are established within hours of tumor antigen encounter before cell division (Nat Immunol.) par le Dr Matthieu Roulleau Dugage, disponible ICI

Revoir en Replay TIJC#3
Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis, JExpMed. 
With Dr Marie ROBERT. REPLAY HERE ! 

Revoir en Replay TIJC#2
The type 2 cytokine Fc–IL-4 revitalizes exhausted CD8+ T cells against cancer, Nature 2024. Par le Dr François-Xavier Danlos, disponible ICI

Revoir en Replay TIJC#1
JAK Inhibitors and Cancer: Friend or Foe? Par le Dr Samuel Bitoun, disponible ICI